IDWeek 2022 will provide a comprehensive overview of the latest research and clinical developments in infectious diseases, including HIV. Take a look at some of the key sessions that will be presented on this topic.
IDWeek 2022, hosted by the Infectious Diseases Society of America, will provide a comprehensive overview of the latest research and clinical developments in infectious diseases. One of the primary areas of focus during the event will be HIV. Take a look at some of the key sessions that will be presented on this topic:
Emerging Innovations in Vaccine Development & Cure Strategies
In one session set to take place on Wednesday, October 19th, Dr. Katharine Bar, an Assistant Professor of Medicine at the University of Pennsylvania, will provide insights autumn of the latest innovations in vaccine development and care strategies for HIV in a session titled “What’s Hot in ID and HIV.”
“The field [of vaccines] has worked for years to understand how some people living with HIV develop broadly neutralizing antibodies,” Dr. Bar explained. “As a result, they have developed new immunogens that attempt to guide the immune system to generate these via vaccination.”
While these vaccines have shown great promise in animal models and early human trials, Dr. Bar stresses the need for a better understanding of how a long-lived HIV reservoir is established, and how it persists through years of antiretroviral therapy. And because these vaccines and care interventions are still in the early phases of development, many infectious disease clinicians may not be aware of the steps that have been made in these areas.
Dr. Marwan Haddad, Medical Director of the Center for Key Populations at Community Health Center, will also discuss the latest information in HIV clinical science, and Dr. Preeti Malani, Professor of Medicine at the University of Michigan, will review the latest literature on ID clinical trials.
A Review of National Policy & Care Delivery
On Thursday, October 20th, a session titled “HIV National Policy and Care Delivery” will provide an overview of two programs focusing on helping low-income patients get access to HIV care. Organized by Dr. Colleen Kelley, Associate Professor at Emory University, will provide an overview of the Ryan White HIV/AIDs Program and the federal initiative to end the HIV epidemics in the U.S. This session will be led by Dr. Alice Thornton, a Professor at the University of Kentucky, and feature insights on the Ryan White HIV/AID program’s evolution and where it’s headed next.
“We all realize, including the federal government and those of us on the ground, that there is a massive implementation gap. These tools are available, but getting them to people who need them and ensuring that they're able to use them and over a lifespan, is a challenge,” Dr. Kelley explained. “How can we take these incredible biomedical tools that we have and make sure that the people who need them have access and benefit across their lifespan despite all these competing factors?”
Dr. Kelley and Dr. Thornton hope that this session will provide a better historical perspective on these issues and help reignite clinicians’ passion to advocate at the local, state, and federal levels for accessible HIV care.